Phase 3 Trial of Trofinetide Recruiting Girls and Young Women with Rett Syndrome in US
A Phase 3 clinical trial is recruiting girls and young women with Rett syndrome to explore the safety and efficacy of the investigational oral therapy trofinetide. The study, named LAVENDER, is planning to enroll 180 girls and women, 5 to 20 years old, at clinical sites in the…